Psychiatric Diagnoses and Comorbidities in a Diverse, Multicity Cohort of Young Transgender Women: Baseline Findings From Project LifeSkills | Adolescent Medicine | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Substance Abuse and Mental Health Services Administration (SAMHSA).  Results From the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: SAMHSA; 2013. HHS Publication (SMA) 13-4795.
2.
Olson  J, Forbes  C, Belzer  M.  Management of the transgender adolescent.  Arch Pediatr Adolesc Med. 2011;165(2):171-176.PubMedGoogle ScholarCrossref
3.
Merikangas  KR, He  JP, Burstein  M,  et al.  Lifetime prevalence of mental disorders in US adolescents: results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A).  J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989.PubMedGoogle ScholarCrossref
4.
Reisner  SL, Vetters  R, Leclerc  M,  et al.  Mental health of transgender youth in care at an adolescent urban community health center.  J Adolesc Health. 2015;56(3):274-279.PubMedGoogle ScholarCrossref
5.
Olson  J, Schrager  SM, Belzer  M,  et al.  Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria.  J Adolesc Health. 2015;57(4):374-380.PubMedGoogle ScholarCrossref
6.
Garofalo  R, Deleon  J, Osmer  E, Doll  M, Harper  GW.  Overlooked, misunderstood and at-risk: exploring the lives and HIV risk of ethnic minority male-to-female transgender youth.  J Adolesc Health. 2006;38(3):230-236.PubMedGoogle ScholarCrossref
7.
Edwards-Leeper  L, Spack  NP.  Psychological evaluation and medical treatment of transgender youth in an interdisciplinary “gender management service” (GeMS) in a major pediatric center.  J Homosex. 2012;59(3):321-336.PubMedGoogle ScholarCrossref
8.
Coulter  RW, Blosnich  JR, Bukowski  LA,  et al.  Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults.  Drug Alcohol Depend. 2015;154:251-259.PubMedGoogle ScholarCrossref
9.
Reisner  SL, Greytak  EA, Parsons  JT, Ybarra  ML.  Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity.  J Sex Res. 2015;52(3):243-256.PubMedGoogle ScholarCrossref
10.
Rowe  C, Santos  G-M, McFarland  W, Wilson  EC.  Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area.  Drug Alcohol Depend. 2015;147:160-166.PubMedGoogle ScholarCrossref
11.
Hotton  AL, Garofalo  R, Kuhns  LM, Johnson  AK.  Substance use as a mediator of the relationship between life stress and sexual risk among young transgender women.  AIDS Educ Prev. 2013;25(1):62-71.PubMedGoogle ScholarCrossref
12.
Clements-Nolle  K, Marx  R, Guzman  R, Katz  M.  HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons.  Am J Public Health. 2001;91(6):915-921.PubMedGoogle ScholarCrossref
13.
Clements-Nolle  K, Marx  R, Katz  M.  Attempted suicide among transgender persons: the influence of gender-based discrimination and victimization.  J Homosex. 2006;51(3):53-69.PubMedGoogle ScholarCrossref
14.
Keuroghlian  AS, Reisner  SL, White  JM, Weiss  RD.  Substance use and treatment of substance use disorders in a community sample of transgender adults.  Drug Alcohol Depend. 2015;152:139-146.PubMedGoogle ScholarCrossref
15.
Reisner  SL, White  JM, Bradford  JB, Mimiaga  MJ.  Transgender health disparities: comparing full cohort and nested matched-pair study designs in a community health center.  LGBT Health. 2014;1(3):177-184.PubMedGoogle ScholarCrossref
16.
Benotsch  EG, Zimmerman  R, Cathers  L,  et al.  Non-medical use of prescription drugs, polysubstance use, and mental health in transgender adults.  Drug Alcohol Depend. 2013;132(1-2):391-394.PubMedGoogle ScholarCrossref
17.
Nuttbrock  L, Hwahng  S, Bockting  W,  et al.  Psychiatric impact of gender-related abuse across the life course of male-to-female transgender persons.  J Sex Res. 2010;47(1):12-23.PubMedGoogle ScholarCrossref
18.
Eaton  WW, Anthony  JC, Gallo  J,  et al.  Natural history of diagnostic interview schedule/DSM-IV major depression: the Baltimore Epidemiologic Catchment Area follow-up.  Arch Gen Psychiatry. 1997;54(11):993-999.PubMedGoogle ScholarCrossref
19.
Susser  E, Schwartz  S, Morabia  A.  Psychiatric Epidemiology: Searching for the Causes of Mental Disorders. New York, NY: Oxford University Press; 2006.
20.
Center for Substance Abuse Treatment. Chapter 4: screening and assessment. In:  Substance Abuse Treatment: Addressing the Specific Needs of Women (Treatment Improvement Protocol [TIP] Series, No. 51.) Rockville, MD: Center for Substance Abuse Treatment; 2009.
21.
Center for Substance Abuse Treatment. Chapter 4: screening and assessment. In:  Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol [TIP] Series, No. 57.) Rockville, MD: Center for Substance Abuse Treatment; 2014.
22.
Stieglitz  KA.  Development, risk, and resilience of transgender youth.  J Assoc Nurses AIDS Care. 2010;21(3):192-206.PubMedGoogle ScholarCrossref
23.
Garofalo  R, Johnson  AK, Kuhns  LM,  et al.  Life skills: evaluation of a theory-driven behavioral HIV prevention intervention for young transgender women.  J Urban Health. 2012;89(3):419-431.PubMedGoogle ScholarCrossref
24.
Leung  MW, Yen  IH, Minkler  M.  Community based participatory research: a promising approach for increasing epidemiology’s relevance in the 21st century.  Int J Epidemiol. 2004;33(3):499-506.PubMedGoogle ScholarCrossref
25.
 Diagnostic and Statistical Manual of Mental Disorders. 4th text rev ed. Washington, DC: American Psychiatric Association; 2000:553-557.
26.
 International Classification of Diseases. 10th ed. Geneva, Switzerland: World Health Organization; 2009.
27.
Sheehan  DV, Lecrubier  Y, Sheehan  KH,  et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry. 1998;59(suppl 20):22-33.PubMedGoogle Scholar
28.
Gail  MH, Benichou  J.  Encyclopedia of Epidemiologic Methods. Chichester, UK: Wiley; 2000.
29.
Nock  MK, Green  JG, Hwang  I,  et al.  Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement.  JAMA Psychiatry. 2013;70(3):300-310.PubMedGoogle ScholarCrossref
30.
McLaughlin  KA, Koenen  KC, Hill  ED,  et al.  Trauma exposure and posttraumatic stress disorder in a national sample of adolescents.  J Am Acad Child Adolesc Psychiatry. 2013;52(8):815-830.e14.PubMedGoogle ScholarCrossref
31.
Arnett  JJ.  Emerging adulthood: a theory of development from the late teens through the twenties.  Am Psychol. 2000;55(5):469-480.PubMedGoogle ScholarCrossref
32.
Kessler  RC, Avenevoli  S, Ries Merikangas  K.  Mood disorders in children and adolescents.  Biol Psychiatry. 2001;49(12):1002-1014.PubMedGoogle ScholarCrossref
33.
Costello  EJ, Pine  DS, Hammen  C,  et al.  Development and natural history of mood disorders.  Biol Psychiatry. 2002;52(6):529-542.PubMedGoogle ScholarCrossref
34.
Arnett  JJ.  The developmental context of substance use in emerging adulthood.  J Drug Issues. 2005;35(2):235-254.Google ScholarCrossref
35.
Sevelius  JM.  Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color.  Sex Roles. 2013;68(11-12):675-689.PubMedGoogle ScholarCrossref
36.
Vance  SR  Jr, Ehrensaft  D, Rosenthal  SM.  Psychological and medical care of gender nonconforming youth.  Pediatrics. 2014;134(6):1184-1192.PubMedGoogle ScholarCrossref
37.
Coleman  E, Bockting  W, Botzer  M,  et al.  Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7.  Int J Transgenderism. 2012;13(4):165-232.Google ScholarCrossref
38.
Reisner  SL, Bradford  J, Hopwood  R,  et al.  Comprehensive transgender healthcare: the gender affirming clinical and public health model of Fenway Health.  J Urban Health. 2015;92(3):584-592.PubMedGoogle ScholarCrossref
39.
Hoertel  N, McMahon  K, Olfson  M,  et al.  A dimensional liability model of age differences in mental disorder prevalence.  J Psychiatr Res. 2015;64:107-113.PubMedGoogle ScholarCrossref
40.
Tegethoff  M, Belardi  A, Stalujanis  E, Meinlschmidt  G.  Association between mental disorders and physical diseases in adolescents from a nationally representative cohort.  Psychosom Med. 2015;77(3):319-332.PubMedGoogle ScholarCrossref
41.
Gates  GJ.  Demographics and LGBT health.  J Health Soc Behav. 2013;54(1):72-74.PubMedGoogle ScholarCrossref
42.
Guss  C, Shumer  D, Katz-Wise  SL.  Transgender and gender nonconforming adolescent care: psychosocial and medical considerations.  Curr Opin Pediatr. 2015;27(4):421-426.PubMedGoogle ScholarCrossref
43.
de Vries  AL, McGuire  JK, Steensma  TD,  et al.  Young adult psychological outcome after puberty suppression and gender reassignment.  Pediatrics. 2014;134(4):696-704.PubMedGoogle ScholarCrossref
44.
Steever  J.  Cross-gender hormone therapy in adolescents.  Pediatr Ann. 2014;43(6):e138-e144.PubMedGoogle ScholarCrossref
45.
Simons  LK, Leibowitz  SF, Hidalgo  MA.  Understanding gender variance in children and adolescents.  Pediatr Ann. 2014;43(6):e126-e131.PubMedGoogle ScholarCrossref
46.
Conron  KJ, Landers  SJ, Reisner  SL, Sell  RL.  Sex and gender in the US health surveillance system.  Am J Public Health. 2014;104(6):970-976.PubMedGoogle ScholarCrossref
47.
Cochran  BN, Peavy  KM, Robohm  JS.  Do specialized services exist for LGBT individuals seeking treatment for substance misuse?  Subst Use Misuse. 2007;42(1):161-176.PubMedGoogle ScholarCrossref
48.
Rosenthal  SM.  Approach to the patient: transgender youth: endocrine considerations.  J Clin Endocrinol Metab. 2014;99(12):4379-4389.PubMedGoogle ScholarCrossref
49.
Costello  EJ, Mustillo  S, Erkanli  A,  et al.  Prevalence and development of psychiatric disorders in childhood and adolescence.  Arch Gen Psychiatry. 2003;60(8):837-844.PubMedGoogle ScholarCrossref
50.
Kessler  RC, Chiu  WT, Demler  O,  et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.  Arch Gen Psychiatry. 2005;62(6):617-627.PubMedGoogle ScholarCrossref
Original Investigation
Journal Club, Adolescent and Young Adult Health
May 2016

Psychiatric Diagnoses and Comorbidities in a Diverse, Multicity Cohort of Young Transgender Women: Baseline Findings From Project LifeSkills

Journal Club PowerPoint Slide Download
Author Affiliations
  • 1Division of General Pediatrics, Boston Children’s Hospital/Harvard Medical School, Boston, Massachusetts
  • 2Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
  • 3The Fenway Institute, Fenway Health, Boston, Massachusetts
  • 4Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island
  • 5Department of Behavioral and Social Health Sciences, Brown University School of Public Health
  • 6Institute for Community Health Promotion, Brown University School of Public Health
  • 7Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
  • 8Division of Adolescent Medicine, Ann & Robert Lurie Children’s Hospital, Chicago, Illinois
  • 9Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 10Division of Infectious Disease, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts
JAMA Pediatr. 2016;170(5):481-486. doi:10.1001/jamapediatrics.2016.0067
Abstract

Importance  Transgender youth, including adolescent and young adult transgender women assigned a male sex at birth who identify as girls, women, transgender women, transfemale, male-to-female, or another diverse transfeminine gender identity, represent a vulnerable population at risk for negative mental health and substance use outcomes. Diagnostic clinical interviews to assess prevalence of mental health, substance dependence, and comorbid psychiatric disorders in young transgender women remain scarce.

Objective  To report the prevalence of mental health, substance dependence, and comorbid psychiatric disorders assessed via clinical diagnostic interview in a high-risk community-recruited sample of young transgender women.

Design, Setting, and Participants  Observational study reporting baseline finding from a diverse sample of 298 sexually active, young transgender women aged 16 through 29 years (mean age, 23.4 years; 49.0% black, 12.4% Latina, 25.5% white, and 13.1% other minority race/ethnicity) and enrolled in Project LifeSkills, an ongoing randomized controlled HIV prevention intervention efficacy trial in Chicago and Boston, between 2012 and 2015.

Exposure  Transfeminine gender identity.

Main Outcomes and Measures  Age- and site-adjusted prevalence and comorbidities of mental health and substance dependence disorders assessed via the Mini-International Neuropsychiatric Interview, including 1 or more diagnoses, 2 or more comorbid diagnoses, major depressive episode (current and lifetime), past 30-day suicidal risk (no/low risk vs moderate/high risk), past 6-month generalized anxiety disorder and posttraumatic stress disorder, and past 12-month alcohol dependence and nonalcohol psychoactive substance use dependence.

Results  Of the 298 transgender women, 41.5% of participants had 1 or more mental health or substance dependence diagnoses; 1 in 5 (20.1%) had 2 or more comorbid psychiatric diagnoses. Prevalence of specific disorders was as follows: lifetime and current major depressive episode, 35.4% and 14.7%, respectively; suicidality, 20.2%; generalized anxiety disorder, 7.9%; posttraumatic stress disorder, 9.8%; alcohol dependence, 11.2%; and nonalcohol psychoactive substance use dependence, 15.2%.

Conclusions and Relevance  Prevalence of psychiatric diagnoses was high in this community-recruited sample of young transgender women. Improving access to routine primary care, diagnostic screening, psychotherapy, and pharmacologic treatments, and retention in care in clinical community-based, pediatric, and adolescent medicine settings are urgently needed to address mental health and substance dependence disorders in this population. Further research will be critical, particularly longitudinal studies across development, to understand risk factors and identify optimal timing and targets for psychosocial interventions.

×